Deborah Waterhouse Speaks Patient Care and the Growth of Digital Medicine

Deborah Waterhouse, the SVP of GlaxoSmithKline (GSK)'s Business Unit, has spent over two decades working across many cultures, with the pharmaceutical industries, with a track record of developing clear strategies, strong alignment and excellent execution to drive shareholder and customer value. She is not only passionate about working in healthcare, but is motivated every day by the opportunity to serve customers and make a difference to patients.Thankfully, we had the opportunity of speaking with Waterhouse, who'll also be a keynote at our annual Pharmaceutical Strategy Conference (PSA), to share her expert opinion on  how technology has impacted the new direction of biopharma, garnering long-term success and what she is excited to learn more about at this year's conference.What are the opportunities and challenges facing the relatively new field of digital medicine, and how is the biopharmaceutical industry tapping into the potential for improved treatment and monitoring?Technology is opening incredible new doors, not only in terms of drug discovery and treatment, but also how we are able to engage and support patients in their day-to-day lives. This is particularly exciting for the field of Primary Care. The possibility of helping a diabetes or asthma patient monitor symptoms in real-time – or, to identify a patient who may be predisposed to risk for those conditions, and monitor warning signs long before symptoms fully present – could change the landscape of dis...
Source: ePharma Summit - Category: Pharmaceuticals Tags: Digital pharma disease management health system Healthcare technology patient care Pharmaceutical Industry pharmaceutical strategy Pharmaceutical Strategy Conference primary care PSA Source Type: blogs